T cell-dependent protective effects of CpG motifs of bacterial DNA in experimental colitis are mediated by CD11c+ dendritic cells
- PMID: 20732920
- DOI: 10.1136/gut.2009.193177
T cell-dependent protective effects of CpG motifs of bacterial DNA in experimental colitis are mediated by CD11c+ dendritic cells
Abstract
Background: Oligodeoxynucleotides (ODNs) containing unmethylated cytosine-guanosine (CpG) sequence motifs constitute the immunostimulatory components of bacterial DNA which potently activate innate immunity. Administration of CpG-ODNs before the onset of experimental colitis prevents intestinal inflammation by induction of colitis-suppressing T cells.
Aims: To identify the interplay between innate and adaptive immune cells finally leading to protective CpG-ODN effects in intestinal inflammation.
Methods: Total splenic cells or purified selected cell types (CD4(+)CD62L(+) T cells alone or with B cells or dendritic cells (DCs)) from BALB/c mice were (co)-incubated in vitro with CpG-ODN for 5 days and CD4(+)CD62L(+) cells were injected intraperitoneally into C.B.-17 SCID (severe combined immunodeficiency) mice. Splenic CD4(+)CD62L(+) T cells were isolated from transgenic donor mice in which CD11c(+) DCs were depleted by diphtheria toxin administration during CpG-ODN treatment and injected into C57BL/6 Rag2(-/-) recipients. Intestinal inflammation was evaluated by histological scoring and cytokine secretion of mesenteric lymph node cells.
Results: CpG-ODN treatment of total splenic cells but not of purified CD4(+)CD62L(+) cells reduced the colitogenic potential of transferred T cells. While CpG-ODN stimulation of co-cultured CD4(+)CD62L(+) and B-cells did not alter the colitogenic potential of T cells, co-incubation of CpG-ODN-stimulated DCs and CD4(+)CD62L(+) cells reduced the colitogenic potential of the T cell population. Depletion of CD11c(+) DCs during CpG-ODN administration in vivo abolished the protective CpG-ODN effects.
Conclusions: CpG-ODN-dependent protective effects in experimental colitis act indirectly on CD4(+)CD62L(+) T cells. While the involvement of B cells could be excluded, CD11c(+) DCs were identified as key mediators of CpG-ODN-induced protection in experimental colitis.
Similar articles
-
CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction.Gastroenterology. 2009 Jan;136(1):278-87. doi: 10.1053/j.gastro.2008.09.022. Epub 2008 Sep 25. Gastroenterology. 2009. PMID: 18952084
-
In vivo CpG DNA/toll-like receptor 9 interaction induces regulatory properties in CD4+CD62L+ T cells which prevent intestinal inflammation in the SCID transfer model of colitis.Gut. 2005 Oct;54(10):1428-36. doi: 10.1136/gut.2004.046946. Epub 2005 May 5. Gut. 2005. PMID: 15879013 Free PMC article.
-
Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis.Gut. 2005 Nov;54(11):1546-52. doi: 10.1136/gut.2004.059451. Epub 2005 Jun 29. Gut. 2005. PMID: 15987795 Free PMC article.
-
The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides.J Leukoc Biol. 2000 Oct;68(4):455-63. J Leukoc Biol. 2000. PMID: 11037965 Review.
-
Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides.Biochim Biophys Acta. 1999 Dec 10;1489(1):107-16. doi: 10.1016/s0167-4781(99)00147-5. Biochim Biophys Acta. 1999. PMID: 10807001 Review.
Cited by
-
Type I and III Interferon in the Gut: Tight Balance between Host Protection and Immunopathology.Front Immunol. 2017 Mar 14;8:258. doi: 10.3389/fimmu.2017.00258. eCollection 2017. Front Immunol. 2017. PMID: 28352268 Free PMC article. Review.
-
Immunomodulatory functions of type I interferons.Nat Rev Immunol. 2012 Jan 6;12(2):125-35. doi: 10.1038/nri3133. Nat Rev Immunol. 2012. PMID: 22222875 Free PMC article. Review.
-
New targets for mucosal healing and therapy in inflammatory bowel diseases.Mucosal Immunol. 2014 Jan;7(1):6-19. doi: 10.1038/mi.2013.73. Epub 2013 Oct 2. Mucosal Immunol. 2014. PMID: 24084775 Review.
-
CpG Adjuvant in Allergen-Specific Immunotherapy: Finding the Sweet Spot for the Induction of Immune Tolerance.Front Immunol. 2021 Feb 23;12:590054. doi: 10.3389/fimmu.2021.590054. eCollection 2021. Front Immunol. 2021. PMID: 33708195 Free PMC article. Review.
-
Regulation of human intestinal T-cell responses by type 1 interferon-STAT1 signaling is disrupted in inflammatory bowel disease.Mucosal Immunol. 2017 Jan;10(1):184-193. doi: 10.1038/mi.2016.44. Epub 2016 May 25. Mucosal Immunol. 2017. PMID: 27220814
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials